Key Sessions
Sarah Snykers
Transforming Cell Therapy Manufacturing: Legend's Journey from Start Up to Commercial Manufacturing and Beyond
Legend Biotech
Rutger Douma
Establishing a Network to Produce Lentiviral Vectors for Carvykti®
Johnson & Johnson Innovative Medicine
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Wednesday 4th November – Day 1 Main Conference - GMT (Greenwich Mean Time, GMTZ)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Wednesday 4th November – Day 1 Main Conference - GMT (Greenwich Mean Time, GMTZ)
search
Streams
Clear
Showing 1 of 1 Streams
Exosomes Europe
08:55 - 09:00
Chairperson's Opening Remarks: Exosomes Europe 2026
09:00 - 09:30
KEYNOTE: Novel platform of glycoengineered sEV for superior drug delivery and gene therapy
- Steffen Goletz, PhD - Full Professor, Head of Biotherapeutic Glycoengineering and Immunology - Institute for Biotechnology & Biomedicine, Danish Technical University
09:30 - 10:00
Cell Line Engineering: Optimising HEK vs. MSC Hubs
- Bernd Giebel - Founder & CTO, Exosla Therapeutics
10:00 - 10:30
From Bioengineering to Scalable Manufacturing: Advancing Extracellular Vesicles for Targeted Therapeutic Applications
- Madhusudhan Reddy Bobbili - Universitätsassistent (Assistant Professor), BOKU University
Showing 1 of 1 Streams
Exosomes Europe
11:15 - 11:45
deVINCI: Engineering extracellular vesicles for tissue-selective delivery of genetic medicine
- Nazma Ilahibaks - CEO & Co-Founder, JAMA Therapeutics
11:45 - 12:15
APN-EV: Stabilising the Functional Form of Adiponectin on Engineered Extracellular Vesicles for Metabolic Disease Therapy
- Robert Mamoun - CEO, Ciloa
12:15 - 12:45
Managing Bioreactor Dynamics: Mitigating Shear Sensitivity in EV Production
- Lior Shaltiel - CEO, NurExone Biologic
Showing 1 of 1 Streams
Exosomes Europe
14:00 - 14:30
Analytical Markers: Distinguishing Natural from Manufactured
14:30 - 15:00
A roadmap to develop potency assay for EV-based product
- Rajeev Tawar - Associate Director, Vector and Analytical Development, Evox Therapeutics
15:00 - 15:30
Scientific Track Presentation: Analytical Precision & Potency Assays
Showing 1 of 1 Streams
Exosomes Europe
16:20 - 16:50
Engineering Targeted Extracellular Vesicles for Translational Drug Delivery
- Alena Ivanova - Senior Scientist, AstraZeneca
16:50 - 17:20
[Clinical Case Study] Targeted by Nature, Powered by Innovation: EXO-CD24 Is Pioneering a New Class of Exosome-Based Therapies
- Shiran Shapira - CTO/CSO, Nano24
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Clear
